Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis

@inproceedings{Philpott2017AttenuationOE,
  title={Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis},
  author={Holly T.A. Philpott and Melissa O'Brien and Jason J McDougall},
  booktitle={Pain},
  year={2017}
}
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain. The aim of this study was to determine whether CBD is anti-nociceptive in OA, and whether inhibition of inflammation by CBD could prevent the development of OA pain and joint neuropathy. Osteoarthritis was induced in male Wistar rats (150-175 g… CONTINUE READING
115
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine

  • Pain and Therapy
  • 2019
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Cannabinoide im täglichen Einsatz: Evidenz – Realität – Vision

  • Journal für Gynäkologische Endokrinologie/Österreich
  • 2019
VIEW 1 EXCERPT

Protective Effect of Alendronate on Lumbar Facet Degeneration in Ovariectomized Rats

  • Medical science monitor : international medical journal of experimental and clinical research
  • 2019

Osteoarthritis pain. Recent advances and controversies.

  • Current opinion in supportive and palliative care
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2000
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers